Advanced search
Publication Cover
International Journal of Chronic Obstructive Pulmonary Disease Volume 12, 2017 - Issue
Submit an article Journal homepage
69
Views
11
CrossRef citations to date
0
Altmetric
Original Research

Risk factors for the discontinuation of roflumilast in patients with chronic obstructive pulmonary disease

Kyung Hoon Kim1 Division of Pulmonary, Allergy and Critical Care Medicine, Department of Internal Medicine, Seoul St Mary’s Hospital, College of Medicine, The Catholic University of Korea, Seoul
,
Hye Seon Kang2 Division of Pulmonary, Allergy and Critical Care Medicine, Department of Internal Medicine, Bucheon St Mary’s Hospital, College of Medicine, The Catholic University of Korea, Bucheon
,
Ju Sang Kim3 Division of Pulmonary Medicine, Department of Internal Medicine, Incheon St Mary’s Hospital, College of Medicine, The Catholic University of Korea, Incheon
,
Hyoung Kyu Yoon4 Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine, Yeouido St Mary’s Hospital, College of Medicine, The Catholic University of Korea, Seoul
,
Sung Kyoung Kim5 Division of Pulmonary Medicine, Department of Internal Medicine, St Vincent’s Hospital, College of Medicine, The Catholic University of Korea, Suwon, Republic of KoreaCorrespondence[email protected]
&
Chin Kook Rhee1 Division of Pulmonary, Allergy and Critical Care Medicine, Department of Internal Medicine, Seoul St Mary’s Hospital, College of Medicine, The Catholic University of Korea, SeoulCorrespondence[email protected]
Pages 3449-3456 | Published online: 04 Dec 2017

Citations (11)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (3)

Jesús Recio Iglesias, Francisco López García, Pere Almagro, José Manuel Varela Aguilar & Ramón Boixeda Viu. (2020) Spanish clinical practice consensus in internal medicine on chronic obstructive pulmonary disease patients with comorbidities (miEPOC). Current Medical Research and Opinion 36:6, pages 1033-1042.
Read now
Tai Sun Park, Jieun Kang, Jae Seung Lee, Yeon-Mok Oh, Sang-Do Lee & Sei Won Lee. (2019) Adherence to roflumilast under dose-escalation strategy in Korean patients with COPD. International Journal of Chronic Obstructive Pulmonary Disease 14, pages 871-879.
Read now
Peter Kardos, Ingo Mokros, Rüdiger Sauer & Claus F Vogelmeier. (2018) Health status in patients with COPD treated with roflumilast: two large noninterventional real-life studies: DINO and DACOTA. International Journal of Chronic Obstructive Pulmonary Disease 13, pages 1455-1468.
Read now

Articles from other publishers (8)

Yazdan Hasani Nourian, Jafar Salimian, Ali Ahmadi, Zahra Salehi, Mehrdad Karimi, Alireza Emamvirdizadeh, Sadegh Azimzadeh Jamalkandi & Mostafa Ghanei. (2023) cAMP-PDE signaling in COPD: Review of cellular, molecular and clinical features. Biochemistry and Biophysics Reports 34, pages 101438.
Crossref
Sun Hye Shin, Sung Ok Kwon, Victor Kim, Edwin Kepner Silverman, Tae-Hyung Kim, Deog Kyeom Kim, Yong Il Hwang, Kwang Ha Yoo, Woo Jin Kim & Hye Yun Park. (2022) Association of body mass index and COPD exacerbation among patients with chronic bronchitis. Respiratory Research 23:1.
Crossref
Mingliang WANG, Wendong WANG, Jiashun WANG & Jun ZHANG. (2022) MiR-155 contribute to airway inflammation in COPD by regulating autophagy via targeting TLR4/NF-ΚB. Food Science and Technology 42.
Crossref
Rachana Mandru, Christine Y. Zhou, Rachel Pauley & Robert M. Burkes. (2021) Considerations for and Mechanisms of Adjunct Therapy in COPD. Journal of Clinical Medicine 10:6, pages 1225.
Crossref
Sugin Lal Jabaris S & Ranju V. (2021) Scope of adjuvant therapy using roflumilast, a PDE-4 inhibitor against COVID-19. Pulmonary Pharmacology & Therapeutics 66, pages 101978.
Crossref
Imane Achir Alispahic, Rikke Sørensen, Josefin Eklöf, Pradeesh Sivapalan, Anders Løkke, Niels Seersholm, Jakob Hedemark Vestergaard & Jens-Ulrik Stæhr Jensen. (2020) Roflumilast in Severely Ill Patients with Chronic Obstructive Pulmonary Disease with Frequent Exacerbations: Risk of Pneumonia Hospitalization and Severe Exacerbations. Journal of Clinical Medicine 9:5, pages 1442.
Crossref
Chin Kook Rhee & Deog Kyeom Kim. (2020) Role of phosphodiesterase-4 inhibitors in chronic obstructive pulmonary disease. The Korean Journal of Internal Medicine 35:2, pages 276-283.
Crossref
Chin Kook Rhee, Ngo Quy Chau, Faisal Yunus, Kazuto Matsunaga & Diahn‐Warng Perng. (2019) Management of COPD in Asia: A position statement of the Asian Pacific Society of Respirology. Respirology 24:10, pages 1018-1025.
Crossref

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.